Clonmel Healthcare is delighted to announce the launch of Nasorinit 137/50 micrograms per actuation Nasal Spray.
Nasorinit is indicated for relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.
Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Medicinal product subject to medical prescription.
Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.
PA 126/358/001. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: October 2024. 2024/ADV/NAS/258H
Read our Latest News Here
Read October IPN Here
